Selected references

  1. Bath-Hextall FJ, Jenkinson C, Humphreys R, et al. Dietary supplements for established atopic eczema. Cochrane.Database.Syst.Rev. 2012;2:CD005205.
  2. Cochat P, Hulton SA, Acquaviva C, et al. Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment. Nephrol.Dial.Transplant. 2012;27(5):1729-1736.
  3. de Jager CA, Oulhaj A, Jacoby R, et al. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial. Int.J.Geriatr.Psychiatry 2012;27(6):592-600.
  4. Debreceni B and Debreceni L. Why do homocysteine-lowering B vitamin and antioxidant E vitamin supplementations appear to be ineffective in the prevention of cardiovascular diseases? Cardiovasc.Ther. 2012;30(4):227-233.
  5. Dror DK and Allen LH. Interventions with vitamins B6, B12 and C in pregnancy. Paediatr.Perinat.Epidemiol. 2012;26 Suppl 1:55-74.
  6. Ford AH and Almeida OP. Effect of homocysteine lowering treatment on cognitive function: a systematic review and meta-analysis of randomized controlled trials. J.Alzheimers.Dis. 2012;29(1):133-149.
  7. Frustaci A, Neri M, Cesario A, et al. Oxidative stress-related biomarkers in autism: systematic review and meta-analyses. Free Radic.Biol.Med. 5-15-2012;52(10):2128-2141.
  8. Grajecki D, Zyriax BC, and Buhling KJ. The effect of micronutrient supplements on female fertility: a systematic review. Arch.Gynecol.Obstet. 2012;285(5):1463-1471.
  9. Hovdenak N and Haram K. Influence of mineral and vitamin supplements on pregnancy outcome. Eur.J.Obstet.Gynecol.Reprod.Biol. 2012;164(2):127-132.
  10. Jesse S and Ludolph AC. [Thiamine, pyridoxine and cobalamine. From myths to pharmacology and clinical practice]. Nervenarzt 2012;83(4):521-532.
  11. Marti-Carvajal AJ, Sola I, Lathyris D, et al. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane.Database.Syst.Rev. 2013;1:CD006612.
  12. Myung SK, Ju W, Cho B, et al. Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials. BMJ 2013;346:f10.
  13. Offringa M and Newton R. Prophylactic drug management for febrile seizures in children. Cochrane.Database.Syst.Rev. 2012;4:CD003031.
  14. Oladapo OT and Fawole B. Treatments for suppression of lactation. Cochrane.Database.Syst.Rev. 2012;9:CD005937.
  15. Shorvon S and Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain 2011;134(Pt 10):2802-2818.

This evidence-based monograph was prepared by The Natural Standard Research Collaboration

www.naturalstandard.com